Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › PARK2 as epigenetic marker for the identification of immune cells, in particular monocytes

PARK2 as epigenetic marker for the identification of immune cells, in particular monocytes

US Patent 11761041 · Granted Sep 19, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CXCR3 as epigenetic marker for the identification of inflammatory immune cells, 2025
Epigenetic markers for the identification of blood sub-cells of type 12025
Epigenetic method to detect and distinguish IPEX and IPEX-like syndromes, in par2025
Method for epigenetic immune cell detection and counting in human blood samples2024
ERGIC1 as epigenetic marker for the identification of immune cells, in particula2024
MVD as epigenetic marker for the identification of immune cells, in particular C2023
MCC as epigenetic marker for the identification of immune cells, in particular b2023
Epigenetic method for the identification of follicular T-helper-(TFH-) cells2023
Amplicon region as epigenetic marker for the identification of non-classical mon2023
Endosialin (CD248) as epigenetic marker for the identification of immune cells, 2023
LRP5 as epigenetic marker for the identification of immune cells, in particular 2023
PDCD1 as epigenetic marker for the identification of immune cells, in particular2023